Swiss All Share Index
|
16 416,79
|
-48,55
|
-0,29 %
|
Analysen zu Swiss All Share Index-Werten
| 24.07.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 24.07.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.07.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 23.07.24 | Givaudan Equal Weight | Barclays Capital | |
| 23.07.24 | Givaudan Equal Weight | Barclays Capital | |
| 23.07.24 | Givaudan Reduce | Baader Bank | |
| 23.07.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 23.07.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 23.07.24 | Givaudan Neutral | UBS AG | |
| 23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.07.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.07.24 | ABB Sell | Deutsche Bank AG | |
| 22.07.24 | Roche Hold | Deutsche Bank AG | |
| 22.07.24 | ABB Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.24 | ABB Market-Perform | Bernstein Research | |
| 19.07.24 | ABB Sell | Deutsche Bank AG | |
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | Novartis Kaufen | DZ BANK | |
| 19.07.24 | Novartis Hold | Deutsche Bank AG | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 19.07.24 | ABB Neutral | UBS AG | |
| 18.07.24 | DocMorris Sell | UBS AG | |
| 18.07.24 | Novartis Outperform | Bernstein Research | |
| 18.07.24 | ABB Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Richemont Buy | Jefferies & Company Inc. | |
| 18.07.24 | Givaudan Hold | Deutsche Bank AG | |
| 18.07.24 | ABB Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.07.24 | ABB Hold | Jefferies & Company Inc. | |
| 18.07.24 | ABB Sector Perform | RBC Capital Markets | |
| 18.07.24 | ABB Market-Perform | Bernstein Research | |
| 17.07.24 | Roche Hold | Jefferies & Company Inc. | |
| 17.07.24 | Richemont Buy | Deutsche Bank AG | |
| 17.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.07.24 | Richemont Buy | UBS AG | |
| 17.07.24 | DocMorris Buy | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.